Laddar...
Tamoxifen Resistance in Breast Cancer
Tamoxifen is a central component of the treatment of estrogen receptor (ER)-positive breast cancer as a partial agonist of ER. It has been clinically used for the last 30 years and is currently available as a chemopreventive agent in women with high risk for breast cancer. The most challenging issue...
Sparad:
| Huvudupphovsman: | |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
The Korean Society of Applied Pharmacology
2012
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3794521/ https://ncbi.nlm.nih.gov/pubmed/24130921 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4062/biomolther.2012.20.3.256 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|